Suita, Japan

Masahiro Tanemura

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Osaka University, Otsuka Pharmaceutical Factory, Inc.. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Tanemura. Retrieved from https://idiyas.com/inventor/masahiro-tanemura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7


 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Osaka, JP (2014)
  • Kure, JP (2014)
  • Suita, JP (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masahiro Tanemura: Innovator in Stem Cell Research

Introduction

Masahiro Tanemura is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of stem cell research, particularly in the area of pancreatic islet transplantation and induced pluripotent stem cells. With a total of 3 patents, his work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

Tanemura's latest patents include a groundbreaking technique for combined islet transplantation using pancreatic islets and adipose tissue-derived stem cells. This invention aims to enhance the graft survival rate of pancreatic islets after transplantation, thereby reducing the number of islets needed to normalize blood glucose levels. By transplanting both pancreatic islets and adipose tissue-derived stem cells together, the technique significantly improves the survival rate of the transplanted islets.

Another notable patent is his method for producing induced pluripotent stem cells. This method focuses on achieving low tumorigenesis potential and high induction efficiency. It involves introducing nucleic acids that facilitate the expression of key genes, such as NANOG, SOX2, OCT3/4, KLF4, LIN28, and c-MYC, into somatic cells.

Career Highlights

Throughout his career, Tanemura has worked with esteemed institutions, including Osaka University and Otsuka Pharmaceutical Factory, Inc. His research has been pivotal in advancing the understanding and application of stem cell technology in regenerative medicine.

Collaborations

Tanemura has collaborated with notable colleagues, including Masaki Mori and Yuichiro Doki. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Masahiro Tanemura's contributions to stem cell research and transplantation techniques highlight his role as an influential inventor in the medical field. His innovative patents have the potential to transform treatment approaches and improve the quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…